Genmab reports trial results for ovarian cancer drug candidate

Should You Buy Intel Stock as Its Foundry Turnaround Takes Shape?

NASDAQ · Markets 1h ago

Paramount Debt Drop Spells Trouble for Borrowers: Credit Weekly

Bloomberg · Markets 1h ago

XLRE vs. RWO: Which Real Estate ETF Offers Better Value

NASDAQ · Markets 1h ago

3 AI-Power Stocks Riding the Same Data Center Boom, Ranked By Risk

NASDAQ · Markets 1h ago

Bloomberg This Weekend 10/3/2026

Bloomberg · Markets Video 1h ago

Tanvi Exports files for IPO: 5 key highlights from gold jewellery maker’s DRHP

LiveMint · Markets 1h ago

Here's the Max Social Security Benefit at Age 62 -- and How to Get It

NASDAQ · Markets 1h ago

Clorox, General Mills, and Constellation Brands Are Down Between 22% and 33%. Here's the Stock to Buy, Even if the Fed Keeps Hiking Interest Rates.

NASDAQ · Markets 2h ago

Coinbase CEO Brian Armstrong Says Bitcoin Has Hit a Bottom. History Says He's Close.

NASDAQ · Markets 2h ago

$1,000 Invested in Walt Disney (DIS) at Its 52-Week Low Is Worth This Much Today

NASDAQ · Markets 2h ago